Abstract
Optic pathway gliomas (OPG) are a common cancer in children with neurofibromatosis type 1.OPGs can cause clinical symptoms such as reduction of visual acuity, alterations of the visual field, pallor of the optical papilla, strabismus, endocrinological alterations up to diencephalic syndrome.The current guidelines provide for wait and see as the main approach if the tumor is not causing visual deterioration and adapting treatment only in the event of significant impairment of the visual function. Therefore, it is essential to early detect the visual deterioration changes as well as the identification of children eligible for treatment. © 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY).
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1601-1606 |
| Numero di pagine | 6 |
| Rivista | Biomedical and Pharmacology Journal |
| Volume | 13 |
| Numero di pubblicazione | 4 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Farmacologia
Keywords
- children
- neurofibromatosis type I
- optic pathway glioma
Fingerprint
Entra nei temi di ricerca di 'Management of Children with Optic Gliomas and Neurofibromatosis Type 1'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver